Home  |  Success Stories  |  Advising  |  Newsletter  |  Speaking  |  Articles  |  Seminars  |  Reports  |  Services  |  About Us  |  Contact Us    
FDA regulatory compliance consulting services - Cerulean weblogo
SmarterCompliance Member LoginMember Login 



grayfade


2008 News Center

You are invited to download, reproduce, transmit and display the following information for your personal use provided you abide by our Terms of Use (click to review).  All images, files, and graphics are the sole copyrighted property of Cerulean Associates LLC.

 

Note:  all press releases are in PDF format and will require the free Adobe Acrobat reader or similar.

December 9:  Lean Compliance Expert, John Avellanet, Publishes New Case Study on Drug, Biologic and Device Development Collaborations.

November 24:  Cerulean Announces New FDA Compliance Teleconferences for Senior Executives and Business Management.

October 23:  Quality by Design Expert, John Avellanet, Publishes New Case Study:  Can Regulatory Compliance and Quality Systems Help Marketing and Business Development?

October 2:  Cerulean's John Avellanet joins with FDA officials to speak to top pharmaceutical executives on the challenges and opportunities faced by Quality by Design and speeding new drug development and approval.  Read the press release.

September 2:  John Avellanet, Cerulean's Managing Director, will help kick off the 2nd day of the 8th Annual Contract Pharma Conference in New Brunswick, New Jersey, on September 26th along with several FDA speakers.  Read the press release.

August 4:  Cerulean publishes tips for competing against generic biologics and pharmaceuticals.  Reprinted from the February issue of SmarterCompliance.  Read the press release or subscribe to the newsletter.

June 24:  Cerulean's managing director, John Avellanet, spoke at BIO in San Diego on lean outsourcing for biotechnology firms.  Read the press release.

June 5:  Practical tips on preventing intellectual property theft were written by Cerulean's managing director and published in the new book, Best Practices in Biotechnology Business DevelopmentRead the press release and see where to buy.

May 22:  Top pharmaceutical and biotechnology executives listened to Cerulean's John Avellanet outline his Lean Compliance approach to minimizing patient risk, maximizing compliance and quality, all while lowering costs during an FDA Expert Briefing.  Read the press release or request a copy of the presentation and audio file.

May 5:  Radio listeners from California to the United Kingdom will listen to Cerulean's managing director be interviewed on "My Technology Lawyer" (on Thursday, May 8) about dysfunctional communications between IT and non-IT.  Read the press release or download the audio-recording (mp3 format).

April 14:  BioProcess International publishes Cerulean's "shared risk" strategy for supplier selection and qualification to minimize biopharmaceutical and medical device supply chain risk.  Read the press release.

April 7:  John Avellanet to reprise his records management talk as a webinar for busy executives and small business owners to help them prove intellectual property ownership and prevent lawsuit liability.  Read the press release.

March 31:  Cerulean's co-founder named to board of directors of international not-for-profit trade association of information technology consultants.  Press release.

March 18:  John Avellanet brought his tobacco litigation and ISO records management and e-discovery experiences to a speech on records management for small businesses and consultancies in Washington, D.C.  Read the press release.

March 5:  "The Gray Sheet" quotes Cerulean's managing director on the FDA's increasing scrutiny of medical device makers and distributors on so-called "silent" or "hidden" recalls in "FDA on the Lookout for Potential Recalls Masked as Service Requests" article in its March 3, 2008 edition.  Read the press release.

February 29:  John Avellanet, Cerulean's managing director, was the speaker at the College of William & Mary's Mason Business School.  Download his presentation or read the press release.

February 26:  Cerulean attends FDA/FDLI joint conference on FDA enforcement trends for 2008-2009.  Read the press release.  Cerulean's managing director has summarized two days of recommendations from officials and panel discussions into a 18-page report.

February 15:  Cerulean publishes tips on using Joint Development Agreements to protect new biotechnology and pharmaceutical intellectual property.  Excerpted from the June 2007 issue of Cerulean's SMARTERCOMPLIANCERead the release.

February 13:  ComplianceOnline has named Cerulean's managing director to their training staff, focused on Quality by Design and IT compliance issues.  Read the press release or sign up for Cerulean's webinar with ComplianceOnline.

February 6:  Cerulean's managing director gave attendees at the January 23rd BIO IT luncheon five ways to speed time to market and increase new product success rate during his review of client case studies and the FDA's Quality by Design initiative.  Read the press release or view the presentation slideshow.

January 31:  The Journal of GXP Compliance pushes Cerulean's strategy article on the five themes of lean compliance to help executives save more than $5,400 per employee.  Read the press release or request a reprint of the article.

January 11:  Journal of Commercial Biotechnology selects Cerulean's managing director to be the official columnist for regulatory compliance, quality systems and preventing intellectual property theft.  Read the press release.

January 9:  Cerulean's managing director to speak at the BIO-IT Coalition in Washington, D.C. on speeding new product time to market with Quality by Design.  See the BIO-IT Coalition's event page for more information or the press release.

January 1:  Cerulean revises website based on input and suggestions from clients and colleagues:  faster page loading, simplified layouts for easier reading and clarification of key expertise (preventing intellectual property theft, computer system compliance, cost-effective lean regulatory compliance, and quality by design).

 

For news releases from previous years, please contact us.